Financial Partners Group LLC Sells 428 Shares of The Procter & Gamble Company (NYSE:PG)

Financial Partners Group LLC trimmed its position in The Procter & Gamble Company (NYSE:PGFree Report) by 3.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,997 shares of the company’s stock after selling 428 shares during the period. Procter & Gamble makes up approximately 0.8% of Financial Partners Group LLC’s investment portfolio, making the stock its 28th largest holding. Financial Partners Group LLC’s holdings in Procter & Gamble were worth $2,078,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Silver Oak Securities Incorporated boosted its holdings in Procter & Gamble by 82.7% during the third quarter. Silver Oak Securities Incorporated now owns 22,254 shares of the company’s stock worth $3,844,000 after purchasing an additional 10,074 shares during the last quarter. Moody Lynn & Lieberson LLC boosted its stake in shares of Procter & Gamble by 2.1% during the 3rd quarter. Moody Lynn & Lieberson LLC now owns 55,751 shares of the company’s stock worth $9,656,000 after buying an additional 1,128 shares during the last quarter. Cross Staff Investments Inc grew its holdings in shares of Procter & Gamble by 1.0% in the 3rd quarter. Cross Staff Investments Inc now owns 7,976 shares of the company’s stock valued at $1,381,000 after acquiring an additional 77 shares in the last quarter. West Michigan Advisors LLC increased its position in shares of Procter & Gamble by 4.1% in the third quarter. West Michigan Advisors LLC now owns 10,330 shares of the company’s stock valued at $1,789,000 after acquiring an additional 407 shares during the last quarter. Finally, Nicholson Wealth Management Group LLC acquired a new position in Procter & Gamble during the third quarter valued at approximately $1,748,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Price Performance

Shares of PG opened at $169.64 on Friday. The business has a 50-day moving average of $171.88 and a 200-day moving average of $167.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a market capitalization of $399.51 billion, a price-to-earnings ratio of 29.25, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.83 EPS. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, COO Shailesh Jejurikar sold 10,623 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $1,797,624.06. Following the transaction, the chief operating officer now directly owns 23,890 shares of the company’s stock, valued at $4,042,665.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 385,186 shares of company stock worth $65,479,358 in the last quarter. Company insiders own 0.18% of the company’s stock.

Analysts Set New Price Targets

PG has been the subject of a number of research analyst reports. Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday. Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Citigroup increased their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday. Finally, Piper Sandler initiated coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.